The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

Rapid Growth of the Market

• The artificial intelligence (AI) in predictive toxicology market is witnessing exponential growth, expanding from $0.38 billion in 2023 to $0.50 billion in 2024 at a compound annual growth rate (CAGR) of 30.3%.
• The surge in market size during this period is driven by several factors including increased regulatory pressure for toxicity assessment, rising concerns about chemical safety, and the availability of large datasets for model training.
• Additionally, the rising costs and ethical concerns associated with animal testing, coupled with the demand for faster and more cost-effective toxicity screening methods, are propelling this market forward.

Key Trends and Future Market Expansion

• Looking ahead, the AI in predictive toxicology market is expected to grow to $1.41 billion by 2028, maintaining a strong CAGR of 29.9%.
• Future growth will be fueled by the emergence of explainable AI in toxicology predictions, an increased demand for personalized toxicity assessments, and regulatory acceptance and standardization of AI-based toxicity predictions.
• Major trends to watch include a shift towards 3D cell culture models for toxicity testing, the rise of federated learning approaches for collaborative toxicity prediction, and the application of generative models for predicting chemical toxicity pathways.
• Additional innovations such as incorporating natural language processing for extracting toxicity data from literature and the growth of virtual screening platforms for prioritizing chemical testing will also contribute to market expansion.

View More On The Artificial Intelligence (AI) In Predictive Toxicology Market Report 2024 – https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report

The Growing Demand for Efficient and Ethical Drug Discovery

• The increasing need for efficient and ethical drug discovery processes is a significant driver of the AI in predictive toxicology market.
• As the drug discovery process becomes more intricate and dynamic, the role of AI in predictive toxicology becomes crucial in efficiently analyzing vast datasets to predict potential toxicological outcomes.
• This technological advancement accelerates drug development while ensuring adherence to ethical standards, a critical factor given the rising prevalence of chronic and age-related diseases.
• For instance, pharmaceutical R&D expenditure in Europe increased by approximately 6.45% in 2022, reflecting the industry’s commitment to advancing drug discovery through AI.

Strategic Collaborations Fueling Innovation

• Major players in the AI predictive toxicology market are increasingly adopting strategic collaborations to enhance their market presence and drive innovation.
• These collaborations often aim to leverage AI and machine learning techniques to improve the prediction and assessment of the toxicity of chemical compounds and pharmaceuticals.
• An example is the partnership between SyntheticGestalt and Enamine in January 2024, focusing on developing AI models that optimize the physicochemical and ADME or Tox properties of compounds.
• Such collaborations not only strengthen the capabilities of these companies but also contribute to the broader goal of advancing AI-driven drug discovery.

Strategic Acquisitions Strengthening Market Position

• Strategic acquisitions are playing a crucial role in amplifying the portfolios and market positions of key players in the AI predictive toxicology market.
• A notable example is Clarivate’s acquisition of Bioinfogate in August 2021, which enhanced Clarivate’s portfolio with the OFF-X portal, improving drug toxicity data and streamlining processes.
• This acquisition signifies a significant advancement in meeting the growing demand for AI in predictive toxicology, further solidifying Clarivate’s position in the life sciences sector.

Conclusion: A Dynamic Market Poised for Continued Growth

• The artificial intelligence in predictive toxicology market is experiencing rapid growth, driven by advancements in technology, increasing demand for ethical drug discovery processes, and strategic collaborations and acquisitions.
• As the market continues to evolve, innovations such as 3D cell culture models, federated learning approaches, and generative models for predicting chemical toxicity pathways will play a pivotal role in shaping the future of this dynamic industry.
• With North America leading the market in 2023 and Asia-Pacific expected to be the fastest-growing region, the AI in predictive toxicology market is well-positioned for sustained expansion in the years to come.

Request A Sample Of The Global Artificial Intelligence (AI) In Predictive Toxicology Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=14253&type=smp